191 related articles for article (PubMed ID: 19117992)
1. PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.
Villar J; Quadri HS; Song I; Tomita Y; Tirado OM; Notario V
Cancer Res; 2009 Jan; 69(1):102-10. PubMed ID: 19117992
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.
Tirado OM; MacCarthy CM; Fatima N; Villar J; Mateo-Lozano S; Notario V
Int J Cancer; 2010 Jan; 126(2):426-36. PubMed ID: 19609943
[TBL] [Abstract][Full Text] [Related]
3. PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism.
Villar J; Arenas MI; MacCarthy CM; Blánquez MJ; Tirado OM; Notario V
Cancer Res; 2007 Nov; 67(22):10859-68. PubMed ID: 18006831
[TBL] [Abstract][Full Text] [Related]
4. The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family.
MacCarthy CM; Notario V
Int J Oncol; 2013 Oct; 43(4):1244-52. PubMed ID: 23921441
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
Mohanty S; Huang J; Basu A
Clin Cancer Res; 2005 Sep; 11(18):6730-7. PubMed ID: 16166454
[TBL] [Abstract][Full Text] [Related]
6. NTPDase5/PCPH as a new target in highly aggressive tumors: a systematic review.
Bracco PA; Bertoni AP; Wink MR
Biomed Res Int; 2014; 2014():123010. PubMed ID: 25045656
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
[TBL] [Abstract][Full Text] [Related]
8. Effect of PKCα expression on Bcl-2 phosphorylation and cell death by hypericin.
Joniova J; Misuth M; Sureau F; Miskovsky P; Nadova Z
Apoptosis; 2014 Dec; 19(12):1779-92. PubMed ID: 25300800
[TBL] [Abstract][Full Text] [Related]
9. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis.
Ruvolo PP; Deng X; Carr BK; May WS
J Biol Chem; 1998 Sep; 273(39):25436-42. PubMed ID: 9738012
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial anchoring of PKCalpha by PICK1 confers resistance to etoposide-induced apoptosis.
Wang WL; Yeh SF; Huang EY; Lu YL; Wang CF; Huang CY; Lin WJ
Apoptosis; 2007 Oct; 12(10):1857-71. PubMed ID: 17610064
[TBL] [Abstract][Full Text] [Related]
11. Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1.
Recio JA; Páez JG; Maskeri B; Loveland M; Velasco JA; Notario V
Cancer Res; 2000 Mar; 60(6):1720-8. PubMed ID: 10749145
[TBL] [Abstract][Full Text] [Related]
12. Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.
Nakano Y; Bilim V; Yuuki K; Muto A; Kato T; Nagaoka A; Tomita Y
Prostate Cancer Prostatic Dis; 2009; 12(1):34-40. PubMed ID: 18475287
[TBL] [Abstract][Full Text] [Related]
13. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
[TBL] [Abstract][Full Text] [Related]
15. Serine phosphorylation of glutathione S-transferase P1 (GSTP1) by PKCα enhances GSTP1-dependent cisplatin metabolism and resistance in human glioma cells.
Singh S; Okamura T; Ali-Osman F
Biochem Pharmacol; 2010 Nov; 80(9):1343-55. PubMed ID: 20654585
[TBL] [Abstract][Full Text] [Related]
16. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
Losert D; Pratscher B; Soutschek J; Geick A; Vornlocher HP; Müller M; Wacheck V
Anticancer Drugs; 2007 Aug; 18(7):755-61. PubMed ID: 17581297
[TBL] [Abstract][Full Text] [Related]
18. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract][Full Text] [Related]
19. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination.
Chanvorachote P; Nimmannit U; Stehlik C; Wang L; Jiang BH; Ongpipatanakul B; Rojanasakul Y
Cancer Res; 2006 Jun; 66(12):6353-60. PubMed ID: 16778213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
